{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T17:57:54Z","timestamp":1769277474695,"version":"3.49.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jdcjournal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Diabetes and its Complications"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.jdiacomp.2016.02.014","type":"journal-article","created":{"date-parts":[[2016,2,21]],"date-time":"2016-02-21T19:00:45Z","timestamp":1456081245000},"page":"580-585","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Anti-apolipoprotein A-1 autoantibodies as risk biomarker for cardiovascular diseases in type 2 diabetes mellitus"],"prefix":"10.1016","volume":"30","author":[{"given":"Dalia","family":"El-Lebedy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enas","family":"Rasheed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mona","family":"Kafoury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dalia","family":"Abd-El Haleem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eman","family":"Awadallah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingy","family":"Ashmawy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl. 1","key":"10.1016\/j.jdiacomp.2016.02.014_bb0005","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.2337\/dc14-S081","article-title":"Diagnosis and classification of diabetes mellitus","volume":"37","author":"American Diabetes Association","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2016.02.014_bb0010","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1210\/jcem.87.1.8183","article-title":"LL-paraoxonase genotype is associated with a more severe degree of homeostasis model assessment IR in healthy subjects","volume":"87","author":"Barbieri","year":"2002","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.jdiacomp.2016.02.014_bb0015","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/rheumatology\/ken397","article-title":"Anti-atherogenic and anti-inflammatory properties of high-density lipoprotein are affected by specific antibodies in systemic lupus erythematosus","volume":"48","author":"Batuca","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jdiacomp.2016.02.014_bb0020","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1196\/annals.1422.016","article-title":"Antibodies toward high-density lipoprotein components inhibit paraoxonase activity in patients with systemic lupus erythematosus","volume":"1108","author":"Batuca","year":"2007","journal-title":"Annals of the New York Academy of Sciences"},{"key":"10.1016\/j.jdiacomp.2016.02.014_bb0025","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.bcp.2004.08.027","article-title":"Modulation of paraoxonase (PON1) activity","volume":"69","author":"Costa","year":"2005","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/j.jdiacomp.2016.02.014_bb0030","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2350-12-7","article-title":"Association analysis of PON genetic variants with serum paraoxonase activity and systemic lupus erythematosus","volume":"12","author":"Dasgupta","year":"2011","journal-title":"BMC Medical Genetics"},{"issue":"5","key":"10.1016\/j.jdiacomp.2016.02.014_bb0035","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1161\/ATVBAHA.107.141747","article-title":"HDL oxidation compromises its influence on paraoxonase-1 secretion and its capacity to modulate enzyme activity","volume":"27","author":"Deakin","year":"2007","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"issue":"10","key":"10.1016\/j.jdiacomp.2016.02.014_bb0040","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1002\/art.10542","article-title":"Antibodies to high-density lipoprotein and beta-2 glycoprotein I are inversely correlated with paraoxonase activity in systemic lupus erythematosus and primary antiphospholipid syndrome","volume":"46","author":"Delgado Alves","year":"2002","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.jdiacomp.2016.02.014_bb0045","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1001\/jama.2009.1619","article-title":"Major lipids, apolipoproteins, and risk of vascular disease","volume":"302","author":"Di Angelantonio","year":"2009","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.jdiacomp.2016.02.014_bb0050","first-page":"124","article-title":"Paraoxonase-1 gene Q192R and L55M polymorphisms and risk of cardiovascular disease in Egyptian patients with type 2 diabetes mellitus","volume":"13","author":"El-Lebedy","year":"2014"},{"issue":"5","key":"10.1016\/j.jdiacomp.2016.02.014_bb0055","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/s11605-008-0502-2","article-title":"Serum paraoxonase undergoes inhibition and proteolysis during experimental acute pancreatitis","volume":"12","author":"Franco-Pons","year":"2008","journal-title":"Journal of Gastrointestinal Surgery"},{"key":"10.1016\/j.jdiacomp.2016.02.014_bb0060","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/684010","article-title":"Regulation of hepatic paraoxonase-1 expression","author":"Fuhrman","year":"2012","journal-title":"Journal of Lipids"},{"issue":"2","key":"10.1016\/j.jdiacomp.2016.02.014_bb0065","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/s11883-010-0097-4","article-title":"Biological properties of apolipoprotein A-I mimetic peptides","volume":"12","author":"Getz","year":"2010","journal-title":"Current Atherosclerosis Reports"},{"key":"10.1016\/j.jdiacomp.2016.02.014_bb0070","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/726048","article-title":"Paraoxonase 1 in chronic kidney failure","author":"Gugliucci","year":"2012","journal-title":"Journal of Lipids"},{"issue":"1","key":"10.1016\/j.jdiacomp.2016.02.014_bb0075","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.chemphyslip.2011.10.005","article-title":"Laboratory investigation of dysfunctional HDL","volume":"165","author":"Guo","year":"2012","journal-title":"Chemistry and Physics of Lipids"},{"issue":"1","key":"10.1016\/j.jdiacomp.2016.02.014_bb0080","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.gene.2012.01.091","article-title":"Low serum PON1 activity: an independent risk factor for coronary artery disease in North-West Indian type 2 diabetics","volume":"498","author":"Gupta","year":"2012","journal-title":"Gene"},{"issue":"3","key":"10.1016\/j.jdiacomp.2016.02.014_bb0085","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1002\/art.27298","article-title":"Should antibodies to high-density lipoprotein cholesterol and its components be measured in all systemic lupus erythematosus patients to predict risk of atherosclerosis?","volume":"62","author":"Hahn","year":"2010","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.jdiacomp.2016.02.014_bb0090","doi-asserted-by":"crossref","DOI":"10.1186\/1475-2840-10-20","article-title":"Non-HDL-cholesterol as valid surrogate to apolipoprotein B100 measurement in diabetes: Discriminant ratio and unbiased equivalence","volume":"10","author":"Hermans","year":"2011","journal-title":"Cardiovascular Diabetology"},{"issue":"2","key":"10.1016\/j.jdiacomp.2016.02.014_bb0095","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/nm.3459","article-title":"ApoA-1 an abundant dysfunctional apolipoprotein A1 in human atheroma","volume":"20","author":"Huang","year":"2014","journal-title":"Nature Medicine"},{"key":"10.1016\/j.jdiacomp.2016.02.014_bb0100","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1016\/j.freeradbiomed.2004.08.012","article-title":"The importance of high-density lipoproteins for paraoxonase-1 secretion, stability, and activity","volume":"37","author":"James","year":"2004","journal-title":"Free Radical Biology and Medicine"},{"issue":"2","key":"10.1016\/j.jdiacomp.2016.02.014_bb0105","first-page":"162","article-title":"AACE Lipid Guidelines Committee. The American Association of Clinical Endocrinologists medical guidelines for clinical practice for the diagnosis and treatment of dyslipidemia and prevention of atherogenesis","volume":"6","author":"Jellinger","year":"2000","journal-title":"Endocrine Practice"},{"key":"10.1016\/j.jdiacomp.2016.02.014_bb0110","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1053\/meta.2001.23291","article-title":"Modulation by blood glucose levels of activity and concentration of paraoxonase in young patients with type 1 diabetes mellitus","volume":"50","author":"Kordonouri","year":"2001","journal-title":"Metabolism - Clinical and Experimental"},{"key":"10.1016\/j.jdiacomp.2016.02.014_bb0115","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1007\/s001250100610","article-title":"The paraoxonase PON1 promoter polymorphism C(\u2212107)T is associated with increased serum glucose concentrations in non-diabetic patients","volume":"44","author":"Leviev","year":"2001","journal-title":"Diabetologia"},{"issue":"2","key":"10.1016\/j.jdiacomp.2016.02.014_bb0120","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/MED.0b013e328327728d","article-title":"HbA1c: How do we measure it and what does it mean?","volume":"16","author":"Little","year":"2009","journal-title":"Current Opinion in Endocrinology, Diabetes, and Obesity"},{"key":"10.1016\/j.jdiacomp.2016.02.014_bb0125","doi-asserted-by":"crossref","first-page":"169","DOI":"10.2147\/DMSO.S61438","article-title":"Importance of cardiovascular disease risk management in patients with type 2 diabetes mellitus","volume":"7","author":"Lorber","year":"2014","journal-title":"Diabetes, Metabolic Syndrome and Obesity"},{"issue":"4","key":"10.1016\/j.jdiacomp.2016.02.014_bb0130","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/eurheartj\/ehq521","article-title":"Anti-Apolipoprotein A-1 auto-antibodies are active mediators of atherosclerotic plaque vulnerability","volume":"32","author":"Montecucco","year":"2011","journal-title":"European Heart Journal"},{"issue":"6","key":"10.1016\/j.jdiacomp.2016.02.014_bb0135","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1194\/jlr.M700439-JLR200","article-title":"HDL subfraction distribution of paraoxonase-1 and its relevance to enzyme activity and resistance to oxidative stress","volume":"49","author":"Moren","year":"2008","journal-title":"Journal of Lipid Research"},{"issue":"1","key":"10.1016\/j.jdiacomp.2016.02.014_bb0140","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/0961203310382429","article-title":"The endothelium: An interface between autoimmunity and atherosclerosis in systemic lupus erythematosus","volume":"20","author":"Narshi","year":"2011","journal-title":"Lupus"},{"issue":"3","key":"10.1016\/j.jdiacomp.2016.02.014_bb0145","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.bbagen.2008.11.009","article-title":"Oxidative inactivation of lactonase activity of purified human paraoxonase 1 (PON1)","volume":"1790","author":"Nguyen","year":"2009","journal-title":"Biochimica et Biophysica Acta - General Subjects"},{"issue":"12","key":"10.1016\/j.jdiacomp.2016.02.014_bb0150","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1080\/5760310001621351-1","article-title":"Oxidative inactivation of paraoxonase1 an antioxidant protein and its effect on antioxidant action","volume":"37","author":"Nguyen","year":"2003","journal-title":"Free Radical Research"},{"issue":"4","key":"10.1016\/j.jdiacomp.2016.02.014_bb0155","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/j.1365-2796.2012.02530.x","article-title":"Anti-apolipoprotein A-1 IgG in patients with myocardial infarction promotes inflammation through TLR2\/CD14 complex","volume":"272","author":"Pagano","year":"2012","journal-title":"Journal of Internal Medicine"},{"issue":"7","key":"10.1016\/j.jdiacomp.2016.02.014_bb0160","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/j.1440-1681.2010.05380.x","article-title":"Anti-oxidant properties of high density lipoprotein and atherosclerosis","volume":"37","author":"Podrez","year":"2010","journal-title":"Clinical and Experimental Pharmacology and Physiology"},{"issue":"1","key":"10.1016\/j.jdiacomp.2016.02.014_bb0165","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.atherosclerosis.2010.08.076","article-title":"The three-gene paraoxonase family: Physiologic roles, actions and regulation","volume":"214","author":"Pr\u00e9court","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jdiacomp.2016.02.014_bb0170","article-title":"Oxidative stress in cardiovascular inflammation: Its involvement in autoimmune responses","volume":"26","author":"Profumo","year":"2011","journal-title":"International Journal of Inflammation"},{"key":"10.1016\/j.jdiacomp.2016.02.014_bb0175","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/j.1744-9987.2012.01102.x","article-title":"High prevalence of anti-apolipoprotein\/A-1 autoantibodies in maintenance hemodialysis and association with dialysis vintage","volume":"16","author":"Pruijm","year":"2012","journal-title":"Therapeutic Apheresis and Dialysis"},{"key":"10.1016\/j.jdiacomp.2016.02.014_bb0180","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/243158","article-title":"Anti-Apolipoprotein A-1 IgG levels predict coronary artery calcification in obese but otherwise healthy individuals","author":"Quercioli","year":"2012","journal-title":"Mediators of Inflammation"},{"key":"10.1016\/j.jdiacomp.2016.02.014_bb0185","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s10067-013-2399-8","article-title":"Anti-apolipoprotein A-1 antibodies and carotid intima- media thickness in Egyptian women with systemic lupus erythematosus","volume":"33","author":"Radwan","year":"2014","journal-title":"Clinical Rheumatology"},{"key":"10.1016\/j.jdiacomp.2016.02.014_bb0190","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1210\/en.2011-1835","article-title":"Antiapolipoprotein A-1 IgG chronotropic effects require nongenomic action of aldosterone on L-type calcium channels","volume":"153","author":"Rossier","year":"2012","journal-title":"Endocrinology"},{"issue":"2","key":"10.1016\/j.jdiacomp.2016.02.014_bb0195","doi-asserted-by":"crossref","first-page":"141","DOI":"10.5455\/medscience.2012.01.141-149","article-title":"HDL-C as a new therapeutic target in the treatment of dyslipidemia","volume":"1","author":"Sahin","year":"2012","journal-title":"Medicine Science"},{"key":"10.1016\/j.jdiacomp.2016.02.014_bb0200","doi-asserted-by":"crossref","first-page":"5422","DOI":"10.1210\/jc.2003-030648","article-title":"Antioxidant paraoxonase 1 activity in the metabolic syndrome","volume":"88","author":"Senti","year":"2003","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"6","key":"10.1016\/j.jdiacomp.2016.02.014_bb0205","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1111\/ene.12074","article-title":"Atherosclerosis and arteriosclerosis parameters in stroke patients associate with paraoxonase polymorphism and esterase activities","volume":"20","author":"Shenhar-Tsarfaty","year":"2013","journal-title":"European Journal of Neurology"},{"key":"10.1016\/j.jdiacomp.2016.02.014_bb0210","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1016\/j.jacc.2011.10.824","volume":"58","author":"Smith","year":"2011","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1016\/j.jdiacomp.2016.02.014_bb0215","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1161\/01.ATV.19.9.2214","article-title":"Human serum paraoxonase\/arylesterase\u2019s retained hydrophobic N-terminal leader sequence associates with HDLs by binding phospholipids: Apolipoprotein A-I stabilizes activity","volume":"19","author":"Sorenson","year":"1999","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"issue":"1","key":"10.1016\/j.jdiacomp.2016.02.014_bb0220","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/art.27764","article-title":"Autoimmune mediated reduction of high density lipoprotein cholesterol and paraoxonase-1 activity in SLE-prone gld mice","volume":"63","author":"Srivastava","year":"2011","journal-title":"Arthritis and Rheumatism"},{"issue":"1","key":"10.1016\/j.jdiacomp.2016.02.014_bb0225","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.freeradbiomed.2010.10.708","article-title":"Human carotid lesion linoleic acid hydroperoxide inhibits paraoxonase 1 (PON1) activity via reaction with PON1 free sulfhydryl cysteine 284","volume":"50","author":"Tavori","year":"2011","journal-title":"Free Radical Biology and Medicine"},{"key":"10.1016\/j.jdiacomp.2016.02.014_bb0230","doi-asserted-by":"crossref","first-page":"410","DOI":"10.2174\/157016112800812755","article-title":"Proteomics investigations of HDL: Challenges and promise","volume":"10","author":"Vaisar","year":"2012","journal-title":"Current Vascular Pharmacology"},{"issue":"9","key":"10.1016\/j.jdiacomp.2016.02.014_bb0240","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1002\/art.27546","article-title":"Anti-apolipoprotein A-1 IgG predicts major cardiovascular events in patients with rheumatoid arthritis","volume":"62","author":"Vuilleumier","year":"2010","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.jdiacomp.2016.02.014_bb0245","doi-asserted-by":"crossref","first-page":"447","DOI":"10.3109\/03009741003742755","article-title":"Anti-apoA-1 IgG and oxidized LDL are raised in rheumatoid arthritis (RA): Potential associations with cardiovascular disease and RA disease activity","volume":"39","author":"Vuilleumier","year":"2010","journal-title":"Scandinavian Journal of Rheumatology"},{"key":"10.1016\/j.jdiacomp.2016.02.014_bb0250","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1042\/CS20070325","article-title":"Anti-(apolipoprotein A-1) IgGs are associated with high levels of oxidized low-density lipoprotein in acute coronary syndrome","volume":"115","author":"Vuilleumier","year":"2008","journal-title":"Clinical Science (London)"},{"issue":"5","key":"10.1016\/j.jdiacomp.2016.02.014_bb0270","doi-asserted-by":"crossref","first-page":"314","DOI":"10.4330\/wjc.v6.i5.314","article-title":"Autoantibodies to apolipoprotein A-1 as a biomarker of cardiovascular autoimmunity","volume":"6","author":"Vuilleumier","year":"2014","journal-title":"World Journal of Cardiology"},{"key":"10.1016\/j.jdiacomp.2016.02.014_bb0255","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1160\/TH12-10-0714","article-title":"Serum levels of anti-apolipoprotein A-1 auto-antibodies and myeloperoxidase as predictors of major adverse cardiovascular events after carotid endarterectomy","volume":"109","author":"Vuilleumier","year":"2013","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1016\/j.jdiacomp.2016.02.014_bb0260","doi-asserted-by":"crossref","first-page":"169","DOI":"10.4172\/2155-9880.1000169","article-title":"Head-to-head comparison of auto-antibodies for cardiovascular outcome prediction after myocardial infarction: A prospective study","volume":"2","author":"Vuilleumier","year":"2011","journal-title":"Journal of Clinical and Experimental Cardiology"},{"key":"10.1016\/j.jdiacomp.2016.02.014_bb0265","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.jaut.2004.08.003","article-title":"Presence of autoantibodies to apolipoprotein A-1 in patients with acute coronary syndrome further links autoimmunity to cardiovascular disease","volume":"23","author":"Vuilleumier","year":"2004","journal-title":"Journal of Autoimmunity"},{"issue":"7","key":"10.1016\/j.jdiacomp.2016.02.014_bb0235","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1093\/eurheartj\/ehq055","article-title":"Anti-apolipoprotein A-1 IgG as an independent cardiovascular prognostic marker affecting basal heart rate in myocardial infarction","volume":"31","author":"Vuilleumier","year":"2010","journal-title":"European Heart Journal"}],"container-title":["Journal of Diabetes and its Complications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872716000726?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872716000726?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,4]],"date-time":"2019-09-04T20:58:38Z","timestamp":1567630718000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1056872716000726"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":54,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["S1056872716000726"],"URL":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2016.02.014","relation":{},"ISSN":["1056-8727"],"issn-type":[{"value":"1056-8727","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-apolipoprotein A-1 autoantibodies as risk biomarker for cardiovascular diseases in type 2 diabetes mellitus","name":"articletitle","label":"Article Title"},{"value":"Journal of Diabetes and its Complications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2016.02.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}